Showing results (2091-2100 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|May 4, 2018
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndromeTianxiang Hu, Qing Wu, Yating Chong, et al.Leukemia|November 1, 1988
T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiationR Nuss, G Kitchingman, A Cross, et al.Leukemia|May 10, 2018
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemiaJolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, et al.Leukemia|May 27, 2017
Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancyK M Grzes, M Swamy, J L Hukelmann, et al.Leukemia|May 31, 2017
Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesisS J Welsh, M L Churchman, M Togni, et al.Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.Leukemia|May 12, 2018
Long intergenic non-coding RNAs have an independent impact on survival in multiple myelomaMehmet Kemal Samur, Stephane Minvielle, Annamaria Gulla, et al.Leukemia|May 24, 2018
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroupsNiccolo Bolli, Giulia Biancon, Matahi Moarii, et al.Leukemia|May 26, 2018
Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug responseKana Sakamoto, Ryohei Katayama, Reimi Asaka, et al.Leukemia|June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studyS K Kumar, M A Dimopoulos, E Kastritis, et al.Pageof 963